A detailed history of Chemistry Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Chemistry Wealth Management LLC holds 8,634 shares of ABBV stock, worth $1.55 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
8,634
Previous 15,159 43.04%
Holding current value
$1.55 Million
Previous $2.6 Million 34.42%
% of portfolio
0.43%
Previous 0.7%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$163.84 - $199.33 $1.07 Million - $1.3 Million
-6,525 Reduced 43.04%
8,634 $1.71 Million
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $820,541 - $958,208
-5,301 Reduced 25.91%
15,159 $2.6 Million
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $38,356 - $43,704
-240 Reduced 1.16%
20,460 $3.73 Million
Q4 2023

Jan 11, 2024

SELL
$137.6 - $154.97 $88,889 - $100,110
-646 Reduced 3.03%
20,700 $3.21 Million
Q3 2023

Oct 11, 2023

SELL
$133.59 - $154.65 $164,716 - $190,683
-1,233 Reduced 5.46%
21,346 $3.18 Million
Q2 2023

Jul 13, 2023

BUY
$132.51 - $164.9 $169,082 - $210,412
1,276 Added 5.99%
22,579 $3.04 Million
Q1 2023

Apr 10, 2023

SELL
$144.61 - $166.54 $66,520 - $76,608
-460 Reduced 2.11%
21,303 $3.4 Million
Q4 2022

Jan 17, 2023

SELL
$138.31 - $165.87 $84,369 - $101,180
-610 Reduced 2.73%
21,763 $0
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $179,975 - $206,420
-1,341 Reduced 5.65%
22,373 $3 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $217,852 - $276,961
-1,583 Reduced 6.26%
23,714 $3.63 Million
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $3.34 Million - $4.14 Million
25,297 New
25,297 $4.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Chemistry Wealth Management LLC Portfolio

Follow Chemistry Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chemistry Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chemistry Wealth Management LLC with notifications on news.